These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20500709)

  • 21. Deep lamellar keratoplasty for corneal perforation due to chronic graft-versus-host disease following allogeneic hematopoietic stem-cell transplantation.
    Yuta K; Kami M; Matsumoto Y; Murashige N; Suzuki S
    Haematologica; 2005 Mar; 90(3):ECR15. PubMed ID: 15753056
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
    Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
    Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
    Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
    Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients.
    Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML
    Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
    Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
    J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease.
    Fricain JC; Sibaud V; Swetyenga N; Tabrizi R; Campana F; Taïeb A
    Br J Dermatol; 2007 Mar; 156(3):588-90. PubMed ID: 17300261
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous manifestations of chronic graft-versus-host disease.
    Hymes SR; Turner ML; Champlin RE; Couriel DR
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1101-13. PubMed ID: 17085303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral erosive lichen planus: think of chronic liver disease].
    Blanchereau C; Pulik M
    Actual Odontostomatol (Paris); 1990 Mar; 44(169):89-94. PubMed ID: 2386103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lichenoid cutaneous chronic GvHD following Blaschko lines.
    Vassallo C; Derlino F; Ripamonti F; Borroni G
    Int J Dermatol; 2014 Apr; 53(4):473-5. PubMed ID: 24320596
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budesonide: a novel treatment for oral chronic graft versus host disease.
    Elad S; Or R; Garfunkel AA; Shapira MY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of oral lesions of chronic lichenoid graft-vs.-host disease by the addition of low-level laser therapy to systemic immunosuppression.
    Chor A; de Azevedo AM; Maiolino A; Nucci M
    Eur J Haematol; 2004 Mar; 72(3):222-4. PubMed ID: 14962242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral graft-versus-host disease.
    Schubert MM; Correa ME
    Dent Clin North Am; 2008 Jan; 52(1):79-109, viii-ix. PubMed ID: 18154866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral manifestations and management of graft-versus-host disease].
    Yang ZP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1987 Jan; 22(1):27-30, 63. PubMed ID: 3304863
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral manifestations of graft-vs-host disease.
    Egbert GW
    J Indiana Dent Assoc; 1985; 64(6):30-3. PubMed ID: 3867747
    [No Abstract]   [Full Text] [Related]  

  • 36. Linear lichenoid graft-vs-host disease.
    Wilson BB; Lockman DW
    Arch Dermatol; 1994 Sep; 130(9):1206-8. PubMed ID: 8085881
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronic oral lichenoid erosions revealing haematological malignancies.
    Ouedraogo E; Gottlieb J; de Masson A; Lepelletier C; Jachiet M; Rybojad M; Bagot M; Galicier L; Bouaziz JD
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):e402-e403. PubMed ID: 29633365
    [No Abstract]   [Full Text] [Related]  

  • 38. Anesthesia and graft-vs-host disease after hematopoietic stem cell transplantation.
    Thiruvenkatarajan V; Rebecca J
    Paediatr Anaesth; 2007 Jan; 17(1):7-15. PubMed ID: 17184425
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation.
    Pereira CM; de Almeida OP; Corrêa ME; Costa FF; de Souza CA; Barjas-Castro ML
    Oral Dis; 2007 May; 13(3):329-34. PubMed ID: 17448218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.